See how the #VisiumHD 3’ whole transcriptome assay powers comprehensive spatial characterization of the tumor microenvironment in our #AACR2025 poster. https://bit.ly/46Q9d6w
September 24, 2025 at 4:00 PM
See how the #VisiumHD 3’ whole transcriptome assay powers comprehensive spatial characterization of the tumor microenvironment in our #AACR2025 poster. https://bit.ly/46Q9d6w
緑のAACR2025 | ShortFilm
https://www.bikingjp.com/713915/
緑のAACR2025 | ShortFilm #AACR2025 2025/05/25 東京 ⇔ 安曇野 １泊２日の旅行（輪行） Shot with DJI OsmoPocket 3 4K 24FPS D-log
The post 緑のAACR2025 | ShortFilm appeared first on Biking Japan.
https://www.bikingjp.com/713915/
緑のAACR2025 | ShortFilm #AACR2025 2025/05/25 東京 ⇔ 安曇野 １泊２日の旅行（輪行） Shot with DJI OsmoPocket 3 4K 24FPS D-log
The post 緑のAACR2025 | ShortFilm appeared first on Biking Japan.
緑のAACR2025 | ShortFilm
緑のAACR2025 | ShortFilm#AACR20252025/05/25 東京 ⇔ 安曇野 １泊２日の旅行（輪行）Shot with DJI OsmoPocket 3 4K 24FPS D-log
www.bikingjp.com
May 28, 2025 at 10:17 AM
緑のAACR2025 | ShortFilm
https://www.bikingjp.com/713915/
緑のAACR2025 | ShortFilm #AACR2025 2025/05/25 東京 ⇔ 安曇野 １泊２日の旅行（輪行） Shot with DJI OsmoPocket 3 4K 24FPS D-log
The post 緑のAACR2025 | ShortFilm appeared first on Biking Japan.
https://www.bikingjp.com/713915/
緑のAACR2025 | ShortFilm #AACR2025 2025/05/25 東京 ⇔ 安曇野 １泊２日の旅行（輪行） Shot with DJI OsmoPocket 3 4K 24FPS D-log
The post 緑のAACR2025 | ShortFilm appeared first on Biking Japan.
RareCyte in collaboration with UCSF developed a novel, highly sensitive assay to detect and characterize CTCs in the cerebrospinal fluid of patients with leptomeningeal disease. Shout out to Laura Huppert who gave an excellent presentation on this work at #AACR2025!
aacrjournals.org/cancerres/ar...
aacrjournals.org/cancerres/ar...
May 27, 2025 at 7:23 PM
RareCyte in collaboration with UCSF developed a novel, highly sensitive assay to detect and characterize CTCs in the cerebrospinal fluid of patients with leptomeningeal disease. Shout out to Laura Huppert who gave an excellent presentation on this work at #AACR2025!
aacrjournals.org/cancerres/ar...
aacrjournals.org/cancerres/ar...
#AACR2025 recap:
•CDR404 (MAGE-A4): Strong activity in "cold" tumors, less T-cell exhaustion, early signs of anti-tumor effect in Ph1
•CDR505 (KK-LC-1): 1st TCE for KK-LC-1+ tumors in HLA-A*01:01 pts—potent, precise, promising
Posters: www.cdr-life.com/our-science/...
•CDR404 (MAGE-A4): Strong activity in "cold" tumors, less T-cell exhaustion, early signs of anti-tumor effect in Ph1
•CDR505 (KK-LC-1): 1st TCE for KK-LC-1+ tumors in HLA-A*01:01 pts—potent, precise, promising
Posters: www.cdr-life.com/our-science/...
May 21, 2025 at 7:31 PM
#AACR2025 recap:
•CDR404 (MAGE-A4): Strong activity in "cold" tumors, less T-cell exhaustion, early signs of anti-tumor effect in Ph1
•CDR505 (KK-LC-1): 1st TCE for KK-LC-1+ tumors in HLA-A*01:01 pts—potent, precise, promising
Posters: www.cdr-life.com/our-science/...
•CDR404 (MAGE-A4): Strong activity in "cold" tumors, less T-cell exhaustion, early signs of anti-tumor effect in Ph1
•CDR505 (KK-LC-1): 1st TCE for KK-LC-1+ tumors in HLA-A*01:01 pts—potent, precise, promising
Posters: www.cdr-life.com/our-science/...
Our #AACR2025 Poster on Clinical #Plasma #Proteomics Is Now Available for Download!
📥 biognosys.com/resources/co...
Attending ASMS 2025?
Join our Breakfast Seminar to dive deep into our latest plasma proteomics advancements!
🗓️ Reserve your seat today: biognosys.com/conferences/...
📥 biognosys.com/resources/co...
Attending ASMS 2025?
Join our Breakfast Seminar to dive deep into our latest plasma proteomics advancements!
🗓️ Reserve your seat today: biognosys.com/conferences/...
May 21, 2025 at 12:59 PM
Our #AACR2025 Poster on Clinical #Plasma #Proteomics Is Now Available for Download!
📥 biognosys.com/resources/co...
Attending ASMS 2025?
Join our Breakfast Seminar to dive deep into our latest plasma proteomics advancements!
🗓️ Reserve your seat today: biognosys.com/conferences/...
📥 biognosys.com/resources/co...
Attending ASMS 2025?
Join our Breakfast Seminar to dive deep into our latest plasma proteomics advancements!
🗓️ Reserve your seat today: biognosys.com/conferences/...
Dr. Rakesh Jain of @mghsteelelabs.bsky.social shared insights from his decades-long work on vascular normalization—from concept to clinic. His lecture emphasized strategies to improve tumor vessel function and how these principles are transforming cancer therapy today.
#AACR2025 @harvard.edu
#AACR2025 @harvard.edu
Ludwig @harvard.edu’s Rakesh Jain, recipient of the #AACR2025 Award for Lifetime Achievement in Cancer Research, told the tale of his 4-decade journey from proposing the vascular normalization hypothesis to seeing it applied today to treat multiple cancers. bit.ly/3Egq1bv
May 19, 2025 at 4:19 PM
Dr. Rakesh Jain of @mghsteelelabs.bsky.social shared insights from his decades-long work on vascular normalization—from concept to clinic. His lecture emphasized strategies to improve tumor vessel function and how these principles are transforming cancer therapy today.
#AACR2025 @harvard.edu
#AACR2025 @harvard.edu
Couldn't attend #AACR2025? Or just didn't get time for the poster hall? We took a hike around the hall and picked out our favourites and compiled them here to get you all caught up! @theaacr.bsky.social www.biotechniques.com/cancer-resea...
Pick of the posters: AACR 2025
Get our top picks of the posters at AACR 2025 and learn more about the method behind them and the techniques used.
www.biotechniques.com
May 15, 2025 at 4:52 PM
Couldn't attend #AACR2025? Or just didn't get time for the poster hall? We took a hike around the hall and picked out our favourites and compiled them here to get you all caught up! @theaacr.bsky.social www.biotechniques.com/cancer-resea...
A Proffered Abstract at #AACR2025:
New from the Human Tumor Atlas Network: Multi-modal profiling of HR+ metastatic breast cancer reveals tumor-intrinsic and microenvironmental programs driving CDK4/6 inhibitor resistance.
Largest spatially resolved MBC cohort to date
aacrjournals.org/cancerres/ar...
New from the Human Tumor Atlas Network: Multi-modal profiling of HR+ metastatic breast cancer reveals tumor-intrinsic and microenvironmental programs driving CDK4/6 inhibitor resistance.
Largest spatially resolved MBC cohort to date
aacrjournals.org/cancerres/ar...
Abstract 6605: Spatially-resolved single-cell transcriptome landscape of response and resistance to CDK4/6 inhibitors in patients with hormone receptor-positive metastatic breast cancer
Abstract. Cyclin-dependent kinase 4/6 inhibitors (CDK4/6i) have significantly improved the treatment of hormone receptor (HR+) positive breast cancer. Clinical trials have demonstrated that addition o...
aacrjournals.org
May 9, 2025 at 4:39 PM
A Proffered Abstract at #AACR2025:
New from the Human Tumor Atlas Network: Multi-modal profiling of HR+ metastatic breast cancer reveals tumor-intrinsic and microenvironmental programs driving CDK4/6 inhibitor resistance.
Largest spatially resolved MBC cohort to date
aacrjournals.org/cancerres/ar...
New from the Human Tumor Atlas Network: Multi-modal profiling of HR+ metastatic breast cancer reveals tumor-intrinsic and microenvironmental programs driving CDK4/6 inhibitor resistance.
Largest spatially resolved MBC cohort to date
aacrjournals.org/cancerres/ar...
New data from #AACR2025 show a steep decline in breast cancer deaths among females aged 20–49. Luminal A and triple-negative types saw the biggest drop. Disparities remain for Black women.
Read the full @amjreviews.bsky.social article here: www.emjreviews.com/en-us/amj/on...
#AMJOncology
Read the full @amjreviews.bsky.social article here: www.emjreviews.com/en-us/amj/on...
#AMJOncology
Sharp Drop in Young Women’s Breast Cancer Deaths: AACR 2025
New SEER data presented at AACR 2025 reveal a sharp decline in breast cancer mortality among women aged 20 to 49 across all subtypes and racial groups, with major progress seen after 2016.
www.emjreviews.com
May 7, 2025 at 7:21 PM
New data from #AACR2025 show a steep decline in breast cancer deaths among females aged 20–49. Luminal A and triple-negative types saw the biggest drop. Disparities remain for Black women.
Read the full @amjreviews.bsky.social article here: www.emjreviews.com/en-us/amj/on...
#AMJOncology
Read the full @amjreviews.bsky.social article here: www.emjreviews.com/en-us/amj/on...
#AMJOncology
New Drugs on the Horizon from #AACR2025!
12 clinical molecules, 12 fresh stories from the frontlines of drug discovery.
The full article covers the science, mechanism of action, and clinical context behind each of these new drug compounds.
Read more: t.co/h10fFwojvX
12 clinical molecules, 12 fresh stories from the frontlines of drug discovery.
The full article covers the science, mechanism of action, and clinical context behind each of these new drug compounds.
Read more: t.co/h10fFwojvX
May 6, 2025 at 10:34 PM
New Drugs on the Horizon from #AACR2025!
12 clinical molecules, 12 fresh stories from the frontlines of drug discovery.
The full article covers the science, mechanism of action, and clinical context behind each of these new drug compounds.
Read more: t.co/h10fFwojvX
12 clinical molecules, 12 fresh stories from the frontlines of drug discovery.
The full article covers the science, mechanism of action, and clinical context behind each of these new drug compounds.
Read more: t.co/h10fFwojvX
🎪 What a week at #AACR2025 in Chicago! 🙌
Big thanks to everyone who stopped by Booth #406 to explore our latest in cancer research 🦀 — from 2D/3D cell culture to #imaging & #microfluidics.
🔬 Here’s a quick look back!
@theaacr.bsky.social
#eventhighlights #canceresearch
Big thanks to everyone who stopped by Booth #406 to explore our latest in cancer research 🦀 — from 2D/3D cell culture to #imaging & #microfluidics.
🔬 Here’s a quick look back!
@theaacr.bsky.social
#eventhighlights #canceresearch
May 6, 2025 at 11:51 AM
🎪 What a week at #AACR2025 in Chicago! 🙌
Big thanks to everyone who stopped by Booth #406 to explore our latest in cancer research 🦀 — from 2D/3D cell culture to #imaging & #microfluidics.
🔬 Here’s a quick look back!
@theaacr.bsky.social
#eventhighlights #canceresearch
Big thanks to everyone who stopped by Booth #406 to explore our latest in cancer research 🦀 — from 2D/3D cell culture to #imaging & #microfluidics.
🔬 Here’s a quick look back!
@theaacr.bsky.social
#eventhighlights #canceresearch
Thanks to everyone who joined us at #AACR2025! 🙌 We shared major #AVITI24 updates, including accelerated DISS rollout 🧬 for spatial, single cell insights. Catch our posters and highlights on CRISPR, Trinity™, and more in our wrap-up ⬇️ bit.ly/4jITE4Q
#DrugDiscovery #CancerResearch
#DrugDiscovery #CancerResearch
May 5, 2025 at 9:37 PM
Thanks to everyone who joined us at #AACR2025! 🙌 We shared major #AVITI24 updates, including accelerated DISS rollout 🧬 for spatial, single cell insights. Catch our posters and highlights on CRISPR, Trinity™, and more in our wrap-up ⬇️ bit.ly/4jITE4Q
#DrugDiscovery #CancerResearch
#DrugDiscovery #CancerResearch
And that’s a wrap on #AACR2025! 🎉
It was a real pleasure connecting with both new and familiar faces. Thanks to everyone who stopped by to chat about single-cell research and what we’re building at ARRALYZE. We really enjoyed the conversations and your curiosity 💚
#SingleCell #Biotech
It was a real pleasure connecting with both new and familiar faces. Thanks to everyone who stopped by to chat about single-cell research and what we’re building at ARRALYZE. We really enjoyed the conversations and your curiosity 💚
#SingleCell #Biotech
May 5, 2025 at 2:09 PM
And that’s a wrap on #AACR2025! 🎉
It was a real pleasure connecting with both new and familiar faces. Thanks to everyone who stopped by to chat about single-cell research and what we’re building at ARRALYZE. We really enjoyed the conversations and your curiosity 💚
#SingleCell #Biotech
It was a real pleasure connecting with both new and familiar faces. Thanks to everyone who stopped by to chat about single-cell research and what we’re building at ARRALYZE. We really enjoyed the conversations and your curiosity 💚
#SingleCell #Biotech
Josef is back from #AACR2025 in Chicago where he presented his poster on "CAR-adapted PIK3CD base editing enhances T cell anti-tumor potency" 📰🔬
Between the numerous sessions, Josef found time to record a short tour of the conference for all those who stayed at home! Link to video: bit.ly/3RL7ozJ 📽️✨
Between the numerous sessions, Josef found time to record a short tour of the conference for all those who stayed at home! Link to video: bit.ly/3RL7ozJ 📽️✨
😢 Our iFIT journey at the Annual Meeting of the American Association for… | iFIT - Cluster of Excellence
😢 Our iFIT journey at the Annual Meeting of the American Association for Cancer Research is slowly coming to an end! 💪 Therefore, our member and research group leader 👨🔬 Josef Leibold took the time ...
bit.ly
May 4, 2025 at 6:39 PM
Josef is back from #AACR2025 in Chicago where he presented his poster on "CAR-adapted PIK3CD base editing enhances T cell anti-tumor potency" 📰🔬
Between the numerous sessions, Josef found time to record a short tour of the conference for all those who stayed at home! Link to video: bit.ly/3RL7ozJ 📽️✨
Between the numerous sessions, Josef found time to record a short tour of the conference for all those who stayed at home! Link to video: bit.ly/3RL7ozJ 📽️✨
AACR 2025 in Focus: Top Highlights from the Annual Meeting
@theaacr.bsky.social
oncodaily.com/blog/aacr284...
#OncoDaily #Oncology #Cancer #Health #Medicine #MedEd #MedOnc #MedNews #AACR2025
@theaacr.bsky.social
oncodaily.com/blog/aacr284...
#OncoDaily #Oncology #Cancer #Health #Medicine #MedEd #MedOnc #MedNews #AACR2025
AACR 2025 in Focus: Top Highlights from the Annual Meeting - OncoDaily
AACR 2025 in Focus: Top Highlights from the Annual Meeting / AACR, AACR2025, AACR25, AACRFellows, AACRLeadership, AACROpeningCeremony, AACRTeamScienceAward,
oncodaily.com
May 2, 2025 at 9:17 PM
AACR 2025 in Focus: Top Highlights from the Annual Meeting
@theaacr.bsky.social
oncodaily.com/blog/aacr284...
#OncoDaily #Oncology #Cancer #Health #Medicine #MedEd #MedOnc #MedNews #AACR2025
@theaacr.bsky.social
oncodaily.com/blog/aacr284...
#OncoDaily #Oncology #Cancer #Health #Medicine #MedEd #MedOnc #MedNews #AACR2025
SCRI expert, Dr. Stephen Strickland presented interim results for SENTI-202 at #AACR2025. This CAR NK cell therapy shows potential in treating relapsed AML, with several patients achieving complete remission. Read more www.usnews.com/news/health-...
#CancerResearch #CAR_NK_Therapy #AML #USNews
#CancerResearch #CAR_NK_Therapy #AML #USNews
May 2, 2025 at 6:55 PM
SCRI expert, Dr. Stephen Strickland presented interim results for SENTI-202 at #AACR2025. This CAR NK cell therapy shows potential in treating relapsed AML, with several patients achieving complete remission. Read more www.usnews.com/news/health-...
#CancerResearch #CAR_NK_Therapy #AML #USNews
#CancerResearch #CAR_NK_Therapy #AML #USNews
We're still buzzing after our Skyline Spatial Reception at #AACR2025
We met with enthusiastic, passionate scientists that came together to deliver key innovations for cancer research. The ACD team were honored to co-host with Leica Biosystems & @indicalabs.bsky.social definitely a night to remember!
We met with enthusiastic, passionate scientists that came together to deliver key innovations for cancer research. The ACD team were honored to co-host with Leica Biosystems & @indicalabs.bsky.social definitely a night to remember!
April 30, 2025 at 6:52 PM
We're still buzzing after our Skyline Spatial Reception at #AACR2025
We met with enthusiastic, passionate scientists that came together to deliver key innovations for cancer research. The ACD team were honored to co-host with Leica Biosystems & @indicalabs.bsky.social definitely a night to remember!
We met with enthusiastic, passionate scientists that came together to deliver key innovations for cancer research. The ACD team were honored to co-host with Leica Biosystems & @indicalabs.bsky.social definitely a night to remember!
#AACR2025, several rows of empty poster boards, some posters were not even attended. Changing interests and themes, crowds mostly focused on DNA repair/cell cycle inhibitors or Degraders. Not so much on CAR-T, Systems biology is lost in translation, not sure where cancer research is headed.
April 30, 2025 at 4:58 PM
#AACR2025, several rows of empty poster boards, some posters were not even attended. Changing interests and themes, crowds mostly focused on DNA repair/cell cycle inhibitors or Degraders. Not so much on CAR-T, Systems biology is lost in translation, not sure where cancer research is headed.
Feeling grateful after an inspiring #AACR2025 in Chicago. High-impact science, great communication, and insightful conversations around AI in cancer research. I closed with my poster—on how we are using AI to predict the oncogenic effect of noncoding mutations.
April 30, 2025 at 4:52 PM
Feeling grateful after an inspiring #AACR2025 in Chicago. High-impact science, great communication, and insightful conversations around AI in cancer research. I closed with my poster—on how we are using AI to predict the oncogenic effect of noncoding mutations.
Trispecific therapy ISB 2001 active in ongoing early #MM trial
#AACR25 #AACR2025
sohoinsider.com/cellular-the...
#AACR25 #AACR2025
sohoinsider.com/cellular-the...
SOHO InsiderTrispecific Myeloma Therapy: ISB 2001 89.5% Rate
Trispecific myeloma therapy ISB 2001 achieves 89.5% response rate in relapsed/refractory MM, per AACR 2025 phase 1 trial data.
sohoinsider.com
April 30, 2025 at 3:00 PM
Trispecific therapy ISB 2001 active in ongoing early #MM trial
#AACR25 #AACR2025
sohoinsider.com/cellular-the...
#AACR25 #AACR2025
sohoinsider.com/cellular-the...
The extra plushies aren’t going to waste - we’re honing our juggling skills! A little laughter goes a long way, and our team sure knows how to have fun. 😎 We are excited for day 4! Make sure to swing by booth #2758 before the plushies are all gone! 🐝
#AACR #AACR25 #AACR2025 #CancerResearch #Abbexa
#AACR #AACR25 #AACR2025 #CancerResearch #Abbexa
April 30, 2025 at 2:46 PM
The extra plushies aren’t going to waste - we’re honing our juggling skills! A little laughter goes a long way, and our team sure knows how to have fun. 😎 We are excited for day 4! Make sure to swing by booth #2758 before the plushies are all gone! 🐝
#AACR #AACR25 #AACR2025 #CancerResearch #Abbexa
#AACR #AACR25 #AACR2025 #CancerResearch #Abbexa
Promising data on D3S-001 at AACR25 - Herbert Loong
@herbloongmd.bsky.social @theaacr.bsky.social
oncodaily.com/science/herb...
#OncoDaily #Oncology #Cancer #Health #Medicine #MedEd #MedOnc #MedNews #AACR25 #AACR2025 #D3S001
@herbloongmd.bsky.social @theaacr.bsky.social
oncodaily.com/science/herb...
#OncoDaily #Oncology #Cancer #Health #Medicine #MedEd #MedOnc #MedNews #AACR25 #AACR2025 #D3S001
Herbert Loong: Promising data on D3S-001 at AACR25 - OncoDaily
Herbert Loong: Promising data on D3S-001 at AACR25 / AACR, AACR25, American Society of Clinical Oncology, ASCO, cancer, D3 Bio, D3S-001, fight against cancer,
oncodaily.com
April 30, 2025 at 2:30 PM
Promising data on D3S-001 at AACR25 - Herbert Loong
@herbloongmd.bsky.social @theaacr.bsky.social
oncodaily.com/science/herb...
#OncoDaily #Oncology #Cancer #Health #Medicine #MedEd #MedOnc #MedNews #AACR25 #AACR2025 #D3S001
@herbloongmd.bsky.social @theaacr.bsky.social
oncodaily.com/science/herb...
#OncoDaily #Oncology #Cancer #Health #Medicine #MedEd #MedOnc #MedNews #AACR25 #AACR2025 #D3S001
Final day at #AACR2025! Visit Booth 2741 to meet the MIMETAS team and learn how we can support your cancer research. Check out our 4 posters:
🧬 Liver fibrosis & gene delivery
🧠 GBM-vasculature
🧫 HCC microenvironment
🧪 CAR-T co-culture
Download posters: mimetas.com/en/posters/
🧬 Liver fibrosis & gene delivery
🧠 GBM-vasculature
🧫 HCC microenvironment
🧪 CAR-T co-culture
Download posters: mimetas.com/en/posters/
April 30, 2025 at 1:24 PM
Final day at #AACR2025! Visit Booth 2741 to meet the MIMETAS team and learn how we can support your cancer research. Check out our 4 posters:
🧬 Liver fibrosis & gene delivery
🧠 GBM-vasculature
🧫 HCC microenvironment
🧪 CAR-T co-culture
Download posters: mimetas.com/en/posters/
🧬 Liver fibrosis & gene delivery
🧠 GBM-vasculature
🧫 HCC microenvironment
🧪 CAR-T co-culture
Download posters: mimetas.com/en/posters/
@theaacr.bsky.social #AACR2025 I was honored to co-chair the “microRNAs and other noncoding RNAs” session at AACR Chicago. Fantastic talks about small molecule inhibitors and novel targets regulating miRNA function/EV transport and lincRNA activity that could lead to novel RNA medicine for cancer.
April 30, 2025 at 1:04 PM
@theaacr.bsky.social #AACR2025 I was honored to co-chair the “microRNAs and other noncoding RNAs” session at AACR Chicago. Fantastic talks about small molecule inhibitors and novel targets regulating miRNA function/EV transport and lincRNA activity that could lead to novel RNA medicine for cancer.